Results

Total Results: 3,901 records

Showing results for "depression".

  1. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - For many patients, single ketamine doses often reduce depressive symptoms within 2 hours, with improvements … symptoms within a few hours or days, exponentially faster than many approved antidepressants.12,13 … symptoms and suicidal ideation within 40 minutes compared with placebo. … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major
  2. hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2b.jsp
    January 01, 2006 - Depression Percent of Depression Stays with Secondary Chronic Conditions or Secondary Mental … Health and Substance Abuse Diagnoses by Age, 2006 SEONDARY CONDITION TYPE PERCENT OF DEPRESSION
  3. hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2c.jsp
    January 01, 2006 - Depression Discharge Prevalence for Depression by Median Income of Patient Zip Code, 2006
  4. hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2a.jsp
    January 01, 2006 - Depression Distribution of Discharges with a Principal Diagnosis of Depression† and All Discharges … by Age Group,* 2006 AGE GROUP PERCENT DISTRIBUTION DEPRESSION ALL DISCHARGES Ages
  5. hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_2d.jsp
    January 01, 2006 - Depression Discharge Prevalence for Depression by Region, 2006 REGION DISCHARGES PER
  6. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-248-fullreport.pdf
    December 01, 2019 - Depressive symptoms can be both prolonged and episodic, recurring over weeks and months (National Research … tracking of treatment goals and outcomes, including assessment of depressive symptoms and functioning … Additionally, minority adolescents may present depressive symptoms differently from non-Latino whites … The use of standardized tools is essential for tracking depressive symptoms and monitoring patient response … Measuring and tracking depressive symptoms is important to improve patient outcomes (Knaup, et al.,
  7. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - and the severity of certain depressive symptoms. … antidepressant, partly due to a hypothesized link between dysfunctional glutamate neurotransmission and depressivesymptoms observed in BPD and MDD.4 Preclinical studies indicate that ketamine’s antidepressant properties … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major … depression.
  8. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - symptoms compared with patients receiving traditional in- person therapy sessions. … symptoms and suicidal ideations within 40 minutes compared with placebo. … symptoms were randomly assigned to complete SPARX or standard in-person behavioral therapy. … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  9. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - symptoms compared with symptoms of patients receiving traditional in-person therapy sessions. … symptoms and suicidal ideations within 40 minutes compared with placebo. … , potentially restoring normal emotional processing and easing depressive symptoms.69 Clinical data … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  10. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
    October 01, 2014 - believe that dysfunction in glutamate neurotransmission may play a major role in the etiology of depressivesymptoms in both bipolar disorder and MDD, although its exact mechanism of action is still unknown … symptoms improved both significantly and rapidly and that these effects lasted from 3 days to several … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  11. cds.ahrq.gov/taxonomy/term/41791
    February 18, 2019 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
    January 30, 2014 - " Depression"Scale"scores"(HADS)"(treatment"M=10.63"[2.67]h"waitlist"M=9.56"[3.09])"suggest" that"participants"experienced"mildKtoKmoderate"depressive"symptoms … $symptoms$(CES"D$M=16$[mild$ depression]S$n=67)$found$a$significant$ reduction$in$depressive$symptoms … $and$anxiety$and$reducing$depressive$symptoms. … $symptoms$ (CES"D$M=16$[mild$ depression]S$n=67)$found$a$ significant$reduction$in$ depressive$symptoms … $Brain$morphometry$changes$and$ depressive$symptoms$after$traumatic$brain$injury.$Psychiatry!
  13. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - believe that dysfunction in glutamate neurotransmission may play a major role in the etiology of depressivesymptoms in both bipolar disorder and MDD, although its exact mechanism of action is still unknown … symptoms improved both significantly and rapidly and that these effects lasted from 3 days to several … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  14. www.ahrq.gov/topics/depression.html
    Topic: Depression Depression is a serious medical illness. … If you are one of the more than 19 million teens and adults in the United States who have depression, … AHRQ has research, tools and resources on depression and how clinicians can help their patients with … depression. … Efficacy and Safety of Screening for Postpartum Depression Screening for Depression in Adults
  15. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
    December 01, 2019 - Depressive symptoms can be both prolonged and episodic, recurring over weeks and months (National Research … Additionally, minority adolescents may present depressive symptoms differently than non-Latino whites … The use of standardized tools is essential for tracking depressive symptoms and monitoring patient response … and regular tracking of treatment goals and outcomes, including assessing depressive symptoms and function … Measuring and tracking depressive symptoms are important to improve patient outcomes (Knaup, et al.,
  16. psnet.ahrq.gov/issue/association-between-physician-depressive-symptoms-and-medical-errors-systematic-review-and
    December 11, 2019 - symptoms and medical errors: A systematic review and meta-analysis Pereira-Lima K, Mata … Association Between Physician Depressive Symptoms and Medical Errors: A Systematic Review and Meta-analysis … symptoms found that physicians who screened positive for depression were associated with medical errors … longitudinal studies, which revealed there was a bidirectional association between physician symptoms of depression … This finding implies that physicians that screen positive for depressive symptoms have a higher risk
  17. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
    January 01, 2012 - believe that dysfunction in glutamate neurotransmission may play a major role in the etiology of depressivesymptoms in both bipolar disorder and MDD, although its exact mechanism of action is still unknown … symptoms improved both significantly and rapidly, and that these effects lasted from three days to … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  18. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
    October 01, 2014 - Researchers believe that dysfunctional glutamate neurotransmission may play a major role in causing depressivesymptoms in both BPD and MDD, although its exact mechanism of action is still unknown.59,61 Studies … symptoms improved both significantly and rapidly and that these effects lasted from 3 days to several … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
    March 29, 2013 - Refinements of note include: • Population: We clarified that the scope includes treatment of subthreshold depressivesymptoms and added treatment during the time of conception. … • Subthreshold depressive symptoms which have become the subject of clinical attention. … Speed and duration of response/remission o Relapse o Recurrence o Change in core depressive symptoms … Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and